Clinuvel Pharmaceuticals buy Savour
Start price
20.03.19
/
50%
€16.90
Target price
07.12.19
-
Performance (%)
-1.89%
End price
07.12.19
€16.58
Summary
This prediction ended on 07.12.19 with a price of €16.58. With a performance of -1.89%, the BUY prediction by Savour finished with a loss. A total of €0.015 was paid as dividends for this prediction. Savour has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Clinuvel Pharmaceuticals | 1.621% | 1.621% | -22.720% | -49.286% |
iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
Comments by Savour for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
Savour stimmt der Buy-Einschätzung von Maxi-Scalibusa zu
Savour stimmt am 20.03.2019 der Buy-Einschätzung von Maxi-Scalibusa mit dem Kursziel 19,5€ zu.
Überschrift: Highflyer
Kursziel geändert auf 0,0
Buy beendet
Stopped prediction by Savour for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€17.85
22.12.19
22.12.19
-
11.07.20
11.07.20
-23.08%
11.07.20
11.07.20
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€16.60
07.12.19
07.12.19
-
22.12.19
22.12.19
7.53%
22.12.19
22.12.19